Commitment COM-397
Post-approval commitment for SFDA-2023-0097. Category: Paediatric Study. Priority: high.
Commitment ID
COM-397
Application
Authority
Saudi Food and Drug Authority
Category
Paediatric Study
Priority
high
Status
In Progress
Due Date
2025-01-22
Completed At
—
Owner
Tomoko Ikeda
Created
2023-07-07
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.